IRIS
CAPRANZANO, PIERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.549
AS - Asia 4.439
EU - Europa 3.358
SA - Sud America 681
AF - Africa 438
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 17.476
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.267
SG - Singapore 2.514
CN - Cina 1.284
RU - Federazione Russa 926
IE - Irlanda 859
UA - Ucraina 593
BR - Brasile 588
IT - Italia 448
CI - Costa d'Avorio 330
VN - Vietnam 299
CA - Canada 241
SE - Svezia 128
KR - Corea 99
GB - Regno Unito 80
IN - India 66
FR - Francia 65
DE - Germania 63
SN - Senegal 43
NL - Olanda 37
AR - Argentina 34
BD - Bangladesh 33
MX - Messico 26
AT - Austria 25
ZA - Sudafrica 25
PL - Polonia 24
UZ - Uzbekistan 24
IQ - Iraq 23
ES - Italia 22
BE - Belgio 19
CH - Svizzera 18
EC - Ecuador 18
FI - Finlandia 18
HK - Hong Kong 14
ID - Indonesia 13
GR - Grecia 12
BJ - Benin 10
IR - Iran 10
TR - Turchia 10
VE - Venezuela 10
JP - Giappone 9
MA - Marocco 9
PK - Pakistan 8
UY - Uruguay 8
PE - Perù 7
CO - Colombia 5
EU - Europa 5
KE - Kenya 5
PY - Paraguay 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
NG - Nigeria 4
NP - Nepal 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BG - Bulgaria 3
EG - Egitto 3
JO - Giordania 3
OM - Oman 3
AL - Albania 2
AU - Australia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
LB - Libano 2
LT - Lituania 2
SA - Arabia Saudita 2
TV - Tuvalu 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KI - Kiribati 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.476
Salva come PNG Salva come JPEG
Città #
Dallas 1.440
Singapore 1.367
Santa Clara 1.130
Dublin 859
Jacksonville 803
Chandler 684
Houston 502
Boardman 401
Moscow 381
Abidjan 330
Ashburn 308
Nanjing 245
Hefei 241
Chicago 240
Andover 214
Cambridge 213
Lawrence 213
Toronto 171
Catania 141
Des Moines 141
Beijing 133
Dong Ket 125
Los Angeles 117
Civitanova Marche 105
Seoul 99
Nanchang 83
Wilmington 83
San Mateo 76
Hebei 63
Ho Chi Minh City 59
São Paulo 55
Shenyang 52
Ottawa 48
Hanoi 47
Jiaxing 47
Saint Petersburg 45
Dakar 43
Council Bluffs 41
Tianjin 39
Buffalo 38
Changsha 38
The Dalles 37
New York 36
Columbus 34
Bremen 31
Washington 31
Amsterdam 22
Rio de Janeiro 22
Brooklyn 21
Norwalk 21
Pune 21
Seattle 21
Phoenix 20
Brussels 19
Kunming 17
Ningbo 17
Falls Church 16
Hangzhou 16
Belo Horizonte 15
Boston 15
San Francisco 15
Helsinki 14
Jinan 14
London 14
Milan 14
Redondo Beach 14
San Jose 14
Hong Kong 13
Johannesburg 13
Warsaw 13
Guangzhou 12
Stockholm 12
Atlanta 11
Den Haag 11
Denver 11
Baghdad 10
Chennai 10
Cotonou 10
Mumbai 10
Haiphong 9
Santos 9
Tokyo 9
Zhengzhou 9
Curitiba 8
Da Nang 8
Dhaka 8
Guayaquil 8
Liberty Lake 8
Montreal 8
Porto Alegre 8
Tehran 8
Ann Arbor 7
Brasília 7
Charlotte 7
Edinburgh 7
Mexico City 7
Montevideo 7
Nuremberg 7
Palermo 7
Santo André 7
Totale 12.290
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 534
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 196
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 165
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry 151
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 145
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 134
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 124
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 123
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 123
Early cardiovascular remodelling in Fabry disease 122
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 121
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 120
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 118
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 118
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 117
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 117
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 114
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 113
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 112
Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry 112
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 107
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 107
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 106
Appraisal of key trials in aortic and mitral fields 105
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: Results of the OPTIMUS-2 study 104
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 103
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 102
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 102
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 101
Current status of transcatheter valve therapy in Europe: results from an EAPCI survey 101
A Novel Mechanism by Which MitraClip Implantation May Favorably Alter the Natural History of Left Ventricular Remodeling in Patients with Mitral Regurgitation: Proposed Role of the Ventricular-Valvular Loop 98
Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems 97
Antiplatelet drug response variability and the role of platelet function testing: A practical guide for interventional cardiologists 97
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 95
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 92
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 92
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 92
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 91
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 91
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 91
Retrograde Approach for Chronic Total Occlusion Percutaneous Coronary Intervention: The Paradox of Choice 90
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 90
Clinical implication of different plaque distribution patterns in distal left main coronary artery 90
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 90
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 90
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 90
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 87
Transcatheter Aortic-Valve Replacement 86
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 85
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 85
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 85
Antithrombotic Management of Elderly Patients With Coronary Artery Disease 84
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 83
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 83
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 83
Feasibility and Outcomes of Repeat Percutaneous Edge-to-Edge Mitral Valve Repair Procedures in Patients at High Risk for Surgery 80
Real world safety and efficacy of the janus tacrolimus-eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting Stent (TEST) registry 80
Update on clinical evidence (Part II): a summary of the main post market studies 80
Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE registry) 80
Strategies and Outcomes of Repeat Mitral Valve Interventions After Failed MitraClip Therapy 79
Short and mid-term benefits of coronary stent system with nanothin Polyzene-F in acute coronary syndromes: preliminary result 79
Parenteral Anticoagulant Agents in PCI 79
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis 78
Impact of direct oral anticoagulants on evolution of post-thrombotic syndrome 78
Risk stratification for secondary prevention with ticagrelor and aspirin: a closer look to patient subsets from the PEGASUS-TIMI 54 trial 78
Revascularization vs. Optimal Medical Therapy in Women with NSTE-ACS 78
Early and Midterm Outcomes of Bioresorbable Scaffolds for Ostial Coronary Lesions: Insights from the GHOST-EU Registry 78
Transfemoral transcatheter aortic-valve replacement should be preferred over surgery in most intermediate-risk patients. 78
Self-apposing STENTYS stent in acute myocardial infarction 78
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 77
Risk stratification after ST-elevation myocardial infarction 77
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 77
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease 77
Percutaneous Coronary Intervention With Everolimus-Eluting Bioresorbable Vascular Scaffolds In Routine Clinical Practice: Early and Mid-Term Outcomes From The European Multicenter GHOST-EU Registry 76
Procedural management of patients with advanced heart failure undergoing MitraClip implantation (from the GRASP registry) 76
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary PCI 76
Serum cotinine levels are associated with increased clopidogrel-induced antiplatelet effects 76
Impact of Residual Platelet Reactivity on reperfusion in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention 76
MitraClip Implantation for the Treatment of New-Onset Systolic Anterior Motion of the Mitral Valve After Transcatheter Aortic Valve Replacement 76
One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy? 75
Bioresorbable everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multi-center GHOST-EU registry 75
Simultaneous plaque rupture and erosion in the same atheroma: insights from two and three-dimensional optical coherence tomography 75
Prasugrel: a novel platelet ADP P2Y(12) receptor antagonist. A review on its mechanism of action and clinical development 75
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 74
Capitolo 2 - Diagnostica cardiovascolare 74
Current status of transcatheter mitral valve therapy in Europe: results from an EAPCI survey (Part II) 74
Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation 74
Gestione della terapia antitrombotica nei pazienti con sanguinamento dopo angioplastica coronarica [Management of antithrombotic therapy in patients with bleeding after percutaneous coronary intervention] 73
Clinical development of selective anticoagulants: a state of the art 73
Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients 73
Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry) 73
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 73
CABG Versus PCI In Diabetic Patients With Multivessel Disease After Risk Stratification By The SYNTAX Score: A Pooled Analysis Of The SYNTAX And FREEDOM Trials 73
Exploring reasons for different bioresorbable scaffolds outcomes in women versus men: The research must go on 72
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement 72
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy 72
Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients. 72
PHARMACODYNAMIC EFFECTS OF DIFFERENT ASPIRIN DOSING REGIMENS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CORONARY ARTERY DISEASE 72
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry 72
Percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation in patients with surgical mitral valve repair failure. 71
Totale 9.658
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.387
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021626 0 0 0 0 0 27 166 4 88 2 181 158
2021/20221.478 169 231 2 24 256 15 223 55 116 1 20 366
2022/20232.435 219 51 19 192 333 437 7 380 679 10 75 33
2023/20241.207 63 216 60 87 51 268 31 50 3 29 199 150
2024/20254.141 32 584 281 173 1.041 412 62 147 381 434 250 344
2025/20265.199 512 442 1.575 422 1.452 796 0 0 0 0 0 0
Totale 17.867